PIGMENT CONTROL CREME ( Hydroquinone USP , 4 % ) RX ONLY FOR EXTERNAL USE ONLY : NOT FOR OPHTHALMIC USE DESCRIPTION Hydroquinone is 1 , 4 - benzendiol , with a chemical formula of C6H6O2 and a molecular weight of 110 . 11 .
The structural formula is : [ MULTIMEDIA ] Each gram of Pigment Control Creme ( Hydroquinone USP , 4 % ) contains Hydroquinone USP 40 mg / gm in a base of Purified Water , Ascorbic Acid , Ascorbyl Palmitate , Beta - Glucan , Caprylyl Glycol , Cetyl Alcohol , Chlorphenesin , Dioscorea Villosa ( Wild Yam ) Root Extract , Disodium EDTA , Glycerin , Glycolic Acid , Phenoxyethanol , Quillaja Saponaria Bark Extract , Smilax Aristolochiifolia Root Extract , Sodium Hydroxide , Sodium Lauryl Sulfate , Sodium Metabisulfite , Sodium Sulfite , Stearyl Alcohol , Tocopheryl Acetate , Yucca Schidigera Root Extract .
[ MULTIMEDIA ] CLINICAL PHARMACOLOGY Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3 , 4 - dihydroxyphenylalanine ( DOPA ) and suppression of other melanocyte metabolic processes .
Exposure to sunlight or ultraviolet light will cause re - pigmentation of bleached areas , which may be prevented by the use of the sunscreen agents .
INDICATIONS AND USAGE Pigment Control Creme is indicated in the gradual bleaching of hyperpigmentation , skin conditions such as chloasma , melasma , freckles , senile lentigines , and other unwanted areas of melanin hyperpigmentation .
CONTRAINDICATIONS Prior history of sensitivity or allergic reaction to this product or any of its ingredients .
The safety of topical Hydroquinone use during pregnancy or in children ( 12 years and under ) has not been established .
WARNINGS Hydroquinone is a skin bleaching agent which may produce undesired effects if not used as directed .
The physician should be familiar with the contents of this insert before prescribing or dispensing this product .
Contains sodium metabisulfite , a sulfite that may cause allergic - type reactions including anaphylactic symptoms and life - threatening or less severe asthmatic episodes in certain susceptible people .
The overall prevalence of sulfite sensitivity in the general population is unknown and probably low .
Sulfite sensitivity is seen more frequently in asthmatic than in non - asthmatic people .
Avoid unnecessary sun exposure , use an effective broad - spectrum sunscreen agent or protective clothing should be worn to cover bleached skin to prevent re - pigmentation from occurring .
Hydroquinone may produce exogenous ochronosis , a gradual blue - black darkening of the skin .
If this condition occurs , discontinue treatment and consult your physician .
Avoid contact with eyes and mucous membranes .
Keep out of reach of children .
In case of accidental ingestion , call a physician or a poison control center immediately .
PRECAUTIONS Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin ; check within 24 hours .
Minor redness is not a contraindication , but where there is itching or vesicle formation or excessive inflammatory response , further treatment is not advised .
Close patient supervision is recommended .
Drug Interactions Patients are cautioned on concomitant use of medications that are known to be photosensitizing .
Carcinogenesis , Mutagenesis , Impairment of Fertility Studies of hydroquinone in animals have demonstrated some evidence of carcinogenicity .
The carcinogenic potential of hydroquinone in humans is unknown .
Pregnancy Category C Animal reproduction studies have not been conducted with topical hydroquinone .
It is also not known whether topical hydroquinone can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity .
Topical hydroquinone should be given to a pregnant woman only if clearly needed .
Nursing Mothers It is not known whether this drug is excreted in human milk .
Because many drugs are excreted in human milk , caution should be exercised when topical hydroquinone is administered to a nursing woman .
Pediatric Use Safety and effectiveness for pediatric patients below the age of 12 years have not been established .
Adverse Reactions The following reactions have been reported : dryness and fissuring of paranasal and infraorbital areas , erythema , and stinging .
Occasional hypersensitivity ( localized contact dermatitis ) may develop .
If this occurs , the medication should be discontinued , and the physician notified immediately .
Overdosage There have been no system reactions reported from the use of topical hydroquinone .
However , treatment should be limited to relatively small areas of the body at one time , since some patients experience a transient skin reddening and a mild burning sensation which does not preclude treatment .
DRUG DOSAGE AND ADMINISTRATION A thin layer of Pigment Control Creme ( Hydroquinone USP , 4 % ) should be applied to the affected area twice daily or as directed by a physician .
If no improvement is seen after 8 - 12 weeks of treatment , use of this product should be discontinued .
There is no recommended dosage for pediatric patients under 12 years of age except under the advice and supervision of a physician .
HOW SUPPLIED Pigment Control Creme ( Hydroquinone USP , 4 % ) is available as follows : 2 . 7 Fl .
Oz .
( 80 mL ) Bottle / NDC 42851 - 037 - 80 1 . 0 fl oz / 30 ml Bottle / NDC 42851 - 037 - 30 STORAGE Store at controlled room temperature : 15 ° - 30 ° C ( 59 ° - 86 ° F ) PIGMENT CONTROL + BLENDING CREME ( Hydroquinone USP , 4 % ) RX ONLY FOR EXTERNAL USE ONLY : NOT FOR OPHTHALMIC USE DESCRIPTION Hydroquinone is 1 , 4 - benzendiol , with a chemical formula of C6H6O2 and a molecular weight of 110 . 11 .
The structural formula is : [ MULTIMEDIA ] Each gram of Pigment Control + Blending Creme contains Hydroquinone USP 40 mg / gm in a base of Ascorbic Acid , Ascorbyl Palmitate , Beta - Glucan , Caprylyl Glycol , Cetyl Alcohol , Chlorphenesin , Dioscorea Villosa ( Wild Yam ) Root Extract , Disodium EDTA , Ethylhexyl Palmitate , Glycerin , Glycolic Acid , Palmitic Acid , Phenoxyethanol , Phenyl Trimethicone , Purified Water , Quillaja Saponaria Bark Extract , Smilax Aristolochiifolia Root Extract , Sodium Hydroxide , Sodium Lauryl Sulfate , Sodium Metabisulfite , Sodium Sulfite , Stearyl Alcohol , Tocopheryl Acetate , Yucca Schidigera Root Extract .
[ MULTIMEDIA ] CLINICAL PHARMACOLOGY Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3 , 4 - dihydroxyphenylalanine ( DOPA ) and suppression of other melanocyte metabolic processes .
Exposure to sunlight or ultraviolet light will cause re - pigmentation of bleached areas , which may be prevented by the use of the sunscreen agents .
INDICATIONS AND USAGE For the gradual bleaching of hyperpigmented skin conditions such as cholasma , melasma , freckles , senile lentigines , and other unwanted areas of melanin hyperpigmentation .
CONTRAINDICATIONS Prior history of sensitivity or allergic reaction to hydroquinone or to any other ingredient in this product .
The safety of topical hydroquinone use during pregnancy or in children ( 12 years and under ) has not been established .
WARNINGS Hydroquinone is a skin bleaching agent which may produce undesired effects if not used as directed .
The physician should be familiar with the contents of this insert before prescribing or dispensing this product .
Contains sodium metabisulfite , a sulfite that may cause allergic - type reactions including anaphylactic symptoms and life - threatening or less severe asthmatic episodes in certain susceptible people .
The overall prevalence of sulfite sensitivity in the general population is unknown and probably low .
Sulfite sensitivity is seen more frequently in asthmatic than in non - asthmatic people .
Avoid unnecessary sun exposure , use an effective broad - spectrum sunscreen agent or protective clothing should be worn to cover bleached skin to prevent re - pigmentation from occurring .
Hydroquinone may produce exogenous ochronosis , a gradual blue - black darkening of the skin .
If this condition occurs , discontinue treatment and consult your physician .
Avoid contact with eyes and mucous membranes .
Keep out of reach of children .
In case of accidental ingestion , call a physician or a poison control center immediately .
PRECAUTIONS Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin ; check within 24 hours .
Minor redness is not a contraindication , but where there is itching or vesicle formation or excessive inflammatory response , further treatment is not advised .
Close patient supervision is recommended .
Drug Interactions Patients are cautioned on concomitant use of medications that are known to be photosensitizing .
Carcinogenesis , Mutagenesis , Impairment of Fertility Studies of hydroquinone in animals have demonstrated some evidence of carcinogenicity .
The carcinogenic potential of hydroquinone in humans is unknown .
Pregnancy Category C Animal reproduction studies have not been conducted with topical hydroquinone .
It is also not known whether topical hydroquinone can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity .
Topical hydroquinone should be given to a pregnant woman only if clearly needed .
Nursing Mothers It is not known whether this drug is excreted in human milk .
Because many drugs are excreted in human milk , caution should be exercised when topical hydroquinone is administered to a nursing woman .
Pediatric Use Safety and effectiveness for pediatric patients below the age of 12 years have not been established .
Adverse Reactions The following reactions have been reported : dryness and fissuring of paranasal and infraorbital areas , erythema , and stinging .
Occasional hypersensitivity ( localized contact dermatitis ) may develop .
If this occurs , the medication should be discontinued , and the physician notified immediately .
Overdosage There have been no system reactions reported from the use of topical hydroquinone .
However , treatment should be limited to relatively small areas of the body at one time , since some patients experience a transient skin reddening and a mild burning sensation which does not preclude treatment .
DRUG DOSAGE AND ADMINISTRATION A thin application of Pigment Control + Blending Creme should be applied to the affected area twice daily or as directed by a physician .
Consult product label for instructions on whether to rub in or not .
There is no recommendation for children under 12 years of age except under the advice and supervision of a physician .
HOW SUPPLIED Pigment Control + Blending Creme ( Hydroquinone USP , 4 % ) is available as follows : 2 . 7 Fl .
Oz .
( 80 mL ) Bottle / NDC 42851 - 036 - 80 1 . 0 Fl .
Oz ( 30 mL ) Bottle / NDC 42851 - 036 - 30 STORAGE Store at controlled room temperature : 15 ° - 30 ° C ( 59 ° - 86 ° F ) PRINCIPAL DISPLAY PANEL - Kit Carton ZO ® SKIN HEALTH BY ZEIN OBAGI MD PIGMENT CONTROL PROGRAM + HYDROQUINONE NDC 42851 - 184 - 60 GENTLE CLEANSER 60 mL / 2 Fl .
Oz .
EXFOLIATING POLISH Net Wt .
16 . 2 g / 0 . 57 Oz .
COMPLEXION RENEWAL PADS 30 Pads PIGMENT CONTROL CRÈME 30 mL / 1 . 0 Fl .
Oz .
DAILY POWER DEFENSE 30 mL / 1 Fl .
Oz .
PIGMENT CONTROL + BLENDING CREME 30 mL / 1 Fl .
Oz .
[ MULTIMEDIA ] [ MULTIMEDIA ]
